Product Code: ETC4471706 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The Thailand Cancer Biomarkers Market is centered on the identification and measurement of biomarkers associated with cancer. These biomarkers play a crucial role in cancer diagnosis, prognosis, and treatment decisions. The market is growing as cancer detection and personalized treatment strategies become increasingly important in Thailand healthcare landscape.
The Cancer Biomarkers market in Thailand is experiencing notable growth, driven by advancements in precision medicine and a growing emphasis on personalized cancer diagnostics. Cancer biomarkers, including genetic and protein markers, play a crucial role in predicting cancer risk, guiding treatment decisions, and monitoring treatment responses. As the oncology landscape in Thailand evolves to include targeted therapies, the cancer biomarkers market is expanding, supported by advancements in biomarker discovery and diagnostic technologies.
The Thailand Cancer Biomarkers market encounters challenges related to the discovery and validation of reliable biomarkers for different cancer types. The complex nature of cancer makes the identification of specific and sensitive biomarkers a formidable task. Additionally, the translation of biomarker research into clinical practice requires extensive validation and regulatory approval. Collaborative research efforts, investment in biomarker discovery technologies, and streamlined regulatory pathways are essential for overcoming these challenges and realizing the potential of cancer biomarkers in improving diagnostics and treatment outcomes.
The Thailand Cancer Biomarkers market played a central role during the COVID-19 pandemic as the oncology sector focused on precision medicine and personalized treatment approaches. The demand for cancer biomarker testing, including genetic and protein markers, surged. Challenges related to delayed cancer screenings influenced market dynamics. However, companies in this sector adapted by providing comprehensive biomarker panels and collaborating with oncologists. The market demonstrated resilience by contributing to the advancement of targeted therapies and early detection in cancer care.
Leading the Thailand Cancer Biomarkers Market, key players such as Thermo Fisher Scientific Inc. and Illumina, Inc. significantly contribute to cancer diagnostics and precision medicine. Thermo Fisher Scientific Inc. offers a diverse range of cancer biomarker testing solutions, impacting areas like genomics and molecular diagnostics in Thailand. Illumina, Inc. specializes in DNA sequencing technologies, providing advanced solutions for cancer biomarker discovery and personalized cancer treatment in Thailand. These companies play a crucial role in advancing the Cancer Biomarkers Market for improved cancer detection, prognosis, and targeted therapies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Cancer Biomarkers Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Cancer Biomarkers Market Revenues & Volume, 2023 & 2028F |
3.3 Thailand Cancer Biomarkers Market - Industry Life Cycle |
3.4 Thailand Cancer Biomarkers Market - Porter's Five Forces |
3.5 Thailand Cancer Biomarkers Market Revenues & Volume Share, By Biomarkers Type, 2023 & 2028F |
3.6 Thailand Cancer Biomarkers Market Revenues & Volume Share, By Cancer Type, 2023 & 2028F |
3.7 Thailand Cancer Biomarkers Market Revenues & Volume Share, By Profiling Technologies, 2023 & 2028F |
3.8 Thailand Cancer Biomarkers Market Revenues & Volume Share, By Application, 2023 & 2028F |
4 Thailand Cancer Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Cancer Biomarkers Market Trends |
6 Thailand Cancer Biomarkers Market, By Types |
6.1 Thailand Cancer Biomarkers Market, By Biomarkers Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Cancer Biomarkers Market Revenues & Volume, By Biomarkers Type, 2020 - 2028F |
6.1.3 Thailand Cancer Biomarkers Market Revenues & Volume, By Protein Biomarkers, 2020 - 2028F |
6.1.4 Thailand Cancer Biomarkers Market Revenues & Volume, By Genetic Biomarkers, 2020 - 2028F |
6.1.5 Thailand Cancer Biomarkers Market Revenues & Volume, By Other Cancer Biomarkers, 2020 - 2028F |
6.2 Thailand Cancer Biomarkers Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Cancer Biomarkers Market Revenues & Volume, By Breast Cancer, 2020 - 2028F |
6.2.3 Thailand Cancer Biomarkers Market Revenues & Volume, By Lung Cancer, 2020 - 2028F |
6.2.4 Thailand Cancer Biomarkers Market Revenues & Volume, By Colorectal Cancer, 2020 - 2028F |
6.2.5 Thailand Cancer Biomarkers Market Revenues & Volume, By Prostate Cancer, 2020 - 2028F |
6.2.6 Thailand Cancer Biomarkers Market Revenues & Volume, By Melanoma, 2020 - 2028F |
6.2.7 Thailand Cancer Biomarkers Market Revenues & Volume, By Leukemia, 2020 - 2028F |
6.2.8 Thailand Cancer Biomarkers Market Revenues & Volume, By Bladder Cancer, 2020 - 2028F |
6.2.9 Thailand Cancer Biomarkers Market Revenues & Volume, By Bladder Cancer, 2020 - 2028F |
6.3 Thailand Cancer Biomarkers Market, By Profiling Technologies |
6.3.1 Overview and Analysis |
6.3.2 Thailand Cancer Biomarkers Market Revenues & Volume, By Omics Technologies, 2020 - 2028F |
6.3.3 Thailand Cancer Biomarkers Market Revenues & Volume, By Imaging Technologies, 2020 - 2028F |
6.3.4 Thailand Cancer Biomarkers Market Revenues & Volume, By Immunoassay, 2020 - 2028F |
6.3.5 Thailand Cancer Biomarkers Market Revenues & Volume, By Bioinformatics, 2020 - 2028F |
6.3.6 Thailand Cancer Biomarkers Market Revenues & Volume, By Cytogenetics, 2020 - 2028F |
6.4 Thailand Cancer Biomarkers Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Thailand Cancer Biomarkers Market Revenues & Volume, By Diagnostics, 2020 - 2028F |
6.4.3 Thailand Cancer Biomarkers Market Revenues & Volume, By Research & Development, 2020 - 2028F |
6.4.4 Thailand Cancer Biomarkers Market Revenues & Volume, By Prognostics, 2020 - 2028F |
6.4.5 Thailand Cancer Biomarkers Market Revenues & Volume, By Risk Assessment, 2020 - 2028F |
6.4.6 Thailand Cancer Biomarkers Market Revenues & Volume, By Other Applications, 2020 - 2028F |
7 Thailand Cancer Biomarkers Market Import-Export Trade Statistics |
7.1 Thailand Cancer Biomarkers Market Export to Major Countries |
7.2 Thailand Cancer Biomarkers Market Imports from Major Countries |
8 Thailand Cancer Biomarkers Market Key Performance Indicators |
9 Thailand Cancer Biomarkers Market - Opportunity Assessment |
9.1 Thailand Cancer Biomarkers Market Opportunity Assessment, By Biomarkers Type, 2023 & 2028F |
9.2 Thailand Cancer Biomarkers Market Opportunity Assessment, By Cancer Type, 2023 & 2028F |
9.3 Thailand Cancer Biomarkers Market Opportunity Assessment, By Profiling Technologies, 2023 & 2028F |
9.4 Thailand Cancer Biomarkers Market Opportunity Assessment, By Application, 2023 & 2028F |
10 Thailand Cancer Biomarkers Market - Competitive Landscape |
10.1 Thailand Cancer Biomarkers Market Revenue Share, By Companies, 2023 |
10.2 Thailand Cancer Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |